share_log

Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying

Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying

Red Cat Holdings和其他两只细价股内部人士正在积极买入
Benzinga Real-time News ·  2022/12/27 06:14

The Dow Jones settled higher by around 175 points on Friday. Investors, meanwhile, focused on some notable insider trades.

道琼斯指数周五收盘上涨约175点。与此同时,投资者关注的是一些值得注意的内幕交易。

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

当内部人士买卖股票时,这表明了他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易员可以在他们的整体投资或交易决策中考虑这一因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是最近几笔值得注意的细价股内幕交易。欲了解更多信息,请查看Benzinga的内幕交易站台。

Erasca

埃拉斯卡

  • The Trade: Erasca, Inc. (NASDAQ:ERAS) Director Arthur James Bristol bought a total of 20,000 shares at an average price of $4.14. To acquire these shares, it cost around $82.8 thousand.
  • What's Happening: Erasca said first patient was dosed in HERKULES-1 Phase 1b trial evaluating ERAS-007 and ERAS-601 MAPKlamp combination in RAS/MAPK pathway-altered solid tumors.
  • What Erasca Does: Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
  • 行业: Erasca,Inc.(纳斯达克:时代)董事亚瑟·詹姆斯·布里斯托尔共买入2万股平均价格为4.14美元。收购这些股份的成本约为82.8万美元。
  • 正在发生的事情:Erasca说,第一名患者在Herkules-1 1b期试验中接受了剂量,评估了RAS/MAPK途径改变的实体瘤中ERAS-007和ERAS-601 MAPKLAMP的组合。
  • 埃拉斯卡做了什么:Erasca Inc.是一家临床阶段的精确肿瘤学公司,专门致力于发现、开发和商业化RAS/MAPK通路驱动的癌症患者的治疗方法。

Cumberland Pharmaceuticals

坎伯兰制药公司

  • The Trade: Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Director Kenneth Krogulski acquired a total of 3,050 shares at an average price of $2.22. The insider spent around $6.78 thousand to buy those shares.
  • What's Happening: Cumberland Pharmaceuticals, last month, posted a profit for its third quarter.
  • What Cumberland Pharmaceuticals Does: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products.
  • 《贸易》: 坎伯兰制药公司。(纳斯达克:CPIX)董事肯尼斯·克罗古尔斯基共购入3,050股平均价格为2.22美元。这位内部人士花了大约67.8万美元购买了这些股票。
  • 发生了什么事?:坎伯兰制药公司上个月公布了第三季度的利润。
  • 坎伯兰制药公司的业务:坎伯兰制药公司是一家专注于品牌处方药产品的收购、开发和商业化的专业制药公司。

Check This Out: Investor Fear Eases After US Stocks Record Gains

看看这个:美股录得涨幅后投资者担忧缓解

Don't forget to check out our premarket coverage here

别忘了在这里查看我们的售前报道

Red Cat Holdings

红猫控股

  • The Trade: Red Cat Holdings, Inc. (NASDAQ:RCAT) Director, Chairman of the Board, CEO Jeffrey M Thompson acquired a total of 3,300 shares at an average price of $0.79. To acquire these shares, it cost around $2.61 thousand.
  • What's Happening: Red Cat recently reported wider-than-expected quarterly loss.
  • What Red Cat Holdings Does: Red Cat Holdings Inc provides products, services, and solutions to the drone industry. It offers First Person View (FPV) video goggles to the drone industry, sells FPV drones and equipment, and provides various software and hardware solutions.
  • 《贸易》: 红猫控股有限公司纳斯达克:RCAT)董事,董事会主席,首席执行官杰弗里·M·汤普森共购入3300股平均价格为0.79美元。收购这些股份的成本约为2.61万美元。
  • 发生了什么事?:红猫最近公布的季度亏损超出预期。
  • 红猫控股是做什么的:红猫控股公司为无人机行业提供产品、服务和解决方案。它向无人机行业提供第一人称观看(FPV)视频护目镜,销售FPV无人机和设备,并提供各种软硬件解决方案。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发